Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Effects in Cancer Cells of the Recombinant l-Methionine Gamma-Lyase from Brevibacterium aurantiacum. Encapsulation in Human Erythrocytes for Sustained l-Methionine Elimination.

Machover D, Rossi L, Hamelin J, Desterke C, Goldschmidt E, Chadefaux-Vekemans B, Bonnarme P, Briozzo P, Kopečný D, Pierigè F, Magnani M, Mollicone R, Haghighi-Rad F, Gaston-Mathé Y, Dairou J, Boucheix C, Saffroy R.

J Pharmacol Exp Ther. 2019 Jun;369(3):489-502. doi: 10.1124/jpet.119.256537. Epub 2019 Apr 2.

PMID:
30940696
2.

Recombinant Methioninase as a DNA Demethylation Agent.

Hoffman RM, Machover D.

Methods Mol Biol. 2019;1866:279-284. doi: 10.1007/978-1-4939-8796-2_22.

PMID:
30725424
3.

Enhancement of 5-Fluorouracil Cytotoxicity by Pyridoxal 5'-Phosphate and Folinic Acid in Tandem.

Machover D, Goldschmidt E, Mollicone R, Haghighi-Rad F, Desterke C, Gaston-Mathé Y, Saffroy R, Boucheix C, Dairou J.

J Pharmacol Exp Ther. 2018 Aug;366(2):238-243. doi: 10.1124/jpet.118.249367. Epub 2018 Jun 1.

PMID:
29858389
4.

A review of the evolution of systemic chemotherapy in the management of colorectal cancer.

Gustavsson B, Carlsson G, Machover D, Petrelli N, Roth A, Schmoll HJ, Tveit KM, Gibson F.

Clin Colorectal Cancer. 2015 Mar;14(1):1-10. doi: 10.1016/j.clcc.2014.11.002. Epub 2014 Nov 15. Review.

5.

Feasibility of cetuximab given with a simplified schedule every 2 weeks in advanced colorectal cancer: a multicenter, retrospective analysis.

Bouchahda M, Macarulla T, Liedo G, Lévi F, Elez ME, Paule B, Karaboué A, Artru P, Tabernero J, Machover D, Innominato P, Goldschmidt E, Bonnet D, Ducreux M, Castagne V, Guimbaud R.

Med Oncol. 2011 Dec;28 Suppl 1:S253-8. doi: 10.1007/s12032-010-9716-8. Epub 2010 Nov 5.

PMID:
21053102
6.

Ventricular tachycardia reveals cardiac infiltration due to mediastinal lymphoma.

Algalarrondo V, Misra SC, Bennani SL, Mabille M, Cavailloles F, Machover D, Slama MS.

Europace. 2010 Sep;12(9):1344-5. doi: 10.1093/europace/euq124. Epub 2010 May 19.

PMID:
20484340
7.

Treatment with rituximab, dexamethasone, high-dose cytarabine, and oxaliplatin (R-DHAOx) produces a strong long-term antitumor effect in previously treated patients with follicular non-Hodgkin's lymphoma.

Machover D, Delmas-Marsalet B, Misra SC, Ulusakarya A, Gumus Y, Frénoy N, Guettier C, Saffroy R, Innominato P, Almohamad W, Brahimi N, Haydar M, Goldschmidt E.

Biomed Pharmacother. 2010 Feb;64(2):83-7. doi: 10.1016/j.biopha.2009.11.001. Epub 2009 Dec 9.

PMID:
20044233
8.

Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer.

Bouchahda M, Adam R, Giacchetti S, Castaing D, Brezault-Bonnet C, Hauteville D, Innominato PF, Focan C, Machover D, Lévi F.

Cancer. 2009 Nov 1;115(21):4990-9. doi: 10.1002/cncr.24549.

9.

Acute renal failure related to oxaliplatin-induced intravascular hemolysis.

Ulusakarya A, Misra S, Haydar M, Habert H, Castagne V, Gumus Y, Delmas-Marsalet B, Machover D.

Med Oncol. 2010 Dec;27(4):1425-6. doi: 10.1007/s12032-009-9263-3. Epub 2009 Jun 30.

PMID:
19565364
10.

Modulation of FU with high-dose folinic acid is effective for treatment of patients with gastric carcinoma.

Machover D, Ulusakarya A, Goldschmidt E.

J Clin Oncol. 2008 Jan 1;26(1):164. doi: 10.1200/JCO.2007.14.5607. No abstract available.

PMID:
18165654
11.

Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy.

Adam R, Aloia T, Lévi F, Wicherts DA, de Haas RJ, Paule B, Bralet MP, Bouchahda M, Machover D, Ducreux M, Castagne V, Azoulay D, Castaing D.

J Clin Oncol. 2007 Oct 10;25(29):4593-602.

PMID:
17925554
12.
13.

Blepharitis induced by epidermal growth factor receptor-targeting therapy.

Ulusakarya A, Gumus Y, Delmas-Marsalet B, Machover D.

Am J Clin Oncol. 2006 Oct;29(5):531. No abstract available.

PMID:
17023793
14.

Symptoms in cancer patients and an unusual tumor: Case 1. Regression of hypertrophic pulmonary osteoarthropathy following chemotherapy for lung metastases of a nasopharyngeal carcinoma.

Ulusakarya A, Gumus Y, Brahimi N, Delmas-Marsalet B, Almohamad W, Misra SC, Goldschmidt E, Haydar M, Machover D.

J Clin Oncol. 2005 Dec 20;23(36):9422-3. No abstract available.

PMID:
16361641
15.

Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.

de Botton S, Sanz MA, Chevret S, Dombret H, Martin G, Thomas X, Mediavilla JD, Recher C, Ades L, Quesnel B, Brault P, Fey M, Wandt H, Machover D, Guerci A, Maloisel F, Stoppa AM, Rayon C, Ribera JM, Chomienne C, Degos L, Fenaux P; European APL Group; PETHEMA Group.

Leukemia. 2006 Jan;20(1):35-41.

PMID:
16307026
16.

Treatment of cancer cells with methioninase produces DNA hypomethylation and increases DNA synthesis.

Machover D, Zittoun J, Saffroy R, Broët P, Giraudier S, Magnaldo T, Goldschmidt E, Debuire B, Orrico M, Tan Y, Mishal Z, Chevallier O, Tonetti C, Jouault H, Ulusakarya A, Tanguy ML, Metzger G, Hoffman RM.

Cancer Res. 2002 Aug 15;62(16):4685-9.

17.

Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma.

Machover D, Delmas-Marsalet B, Misra SC, Gumus Y, Goldschmidt E, Schilf A, Frénoy N, Emile JF, Debuire B, Guettier C, Farrokhi P, Boulefdaoui B, Norol F, Parquet N, Ulusakarya A, Jasmin C.

Ann Oncol. 2001 Oct;12(10):1439-43.

PMID:
11762817
18.

Prevention of pathologies associated with oxidative stress and dietary intake deficiencies: folate deficiency and requirements.

Tapiero H, Tew KD, Gaté L, Machover D.

Biomed Pharmacother. 2001 Sep;55(7):381-90. Review.

PMID:
11669501
19.

Association of a POEMS syndrome and light chain deposit disease: first case report.

Lambotte O, Dürrbach A, Ammor M, Paradis V, Djeffal R, Machover D, Charpentier B.

Clin Nephrol. 2001 Jun;55(6):482-6. Review.

PMID:
11434361
20.

Cytotoxic synergism of methioninase in combination with 5-fluorouracil and folinic acid.

Machover D, Zittoun J, Broët P, Metzger G, Orrico M, Goldschmidt E, Schilf A, Tonetti C, Tan Y, Delmas-Marsalet B, Luccioni C, Falissard B, Hoffman RM.

Biochem Pharmacol. 2001 Apr 1;61(7):867-76.

PMID:
11274973
21.

Large scale recovery and characterization of stromal cell-associated primitive haemopoietic progenitor cells from filter-retained human bone marrow.

Blazsek I, Delmas Marsalet B, Legras S, Marion S, Machover D, Misset JL.

Bone Marrow Transplant. 1999 Apr;23(7):647-57.

22.

Leukaemic presentation of small cell variant anaplastic large cell lymphoma: report of four cases.

Bayle C, Charpentier A, Duchayne E, Manel AM, Pages MP, Robert A, Lamant L, Dastugue N, Bertrand Y, Dijoud F, Emile JF, Machover D, Brugiéres L, Delsol G.

Br J Haematol. 1999 Mar;104(4):680-8.

PMID:
10192426
23.
24.

[Chemotherapy for gynecologic tumors].

Machover D.

Contracept Fertil Sex. 1996 Apr;24(4):264-7. Review. French. No abstract available.

PMID:
8704799
25.

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines.

Machover D, Diaz-Rubio E, de Gramont A, Schilf A, Gastiaburu JJ, Brienza S, Itzhaki M, Metzger G, N'Daw D, Vignoud J, Abad A, Francois E, Gamelin E, Marty M, Sastre J, Seitz JF, Ychou M.

Ann Oncol. 1996 Jan;7(1):95-8.

PMID:
9081400
26.

Bone marrow stromal cell defects and 1 alpha,25-dihydroxyvitamin D3 deficiency underlying human myeloid leukemias.

Blazsek I, Farabos C, Quittet P, Labat ML, Bringuier AF, Triana BK, Machover D, Reynes M, Misset JL.

Cancer Detect Prev. 1996;20(1):31-42.

PMID:
8907201
28.

5-Fluorouracil combined with the [6S]-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma. A phase I-II study of two consecutive regimens.

Machover D, Grison X, Goldschmidt E, Zittoun J, Metzger G, Richaud J, Lotz JP, André T, Hannoun L, Marquet J, et al.

Ann Oncol. 1993;4 Suppl 2:29-35.

PMID:
8353102
29.

5-Fluorouracil combined with the pure [6S]-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma: a phase I-II study of two consecutive regimens.

Machover D, Grison X, Goldschmidt E, Zittoun J, Lotz JP, Metzger G, Richaud J, Hannoun L, Marquet J, Guillot T, et al.

Adv Exp Med Biol. 1993;339:81-95; discussion 97-8. No abstract available.

PMID:
8178732
30.

Fluorouracil combined with the pure (6S)-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma: a phase I-II study.

Machover D, Grison X, Goldschmidt E, Zittoun J, Lotz JP, Metzger G, Richaud J, Hannoun L, Marquet J, Guillot T, et al.

J Natl Cancer Inst. 1992 Mar 4;84(5):321-7.

PMID:
1738182
31.

Phase I-II study of two consecutive courses of high-dose epipodophyllotoxin, ifosfamide, and carboplatin with autologous bone marrow transplantation for treatment of adult patients with solid tumors.

Lotz JP, Machover D, Malassagne B, Hingh B, Donsimoni R, Gumus Y, Gerota J, Lam Y, Tulliez M, Marsiglia H, et al.

J Clin Oncol. 1991 Oct;9(10):1860-70.

PMID:
1919636
32.

Developments of the fluoropyrimidines as inhibitors of thymidylate synthetase: pharmacologic and clinical aspects.

Machover D.

J Surg Oncol Suppl. 1991;2:42-50. Review. No abstract available.

PMID:
1832540
33.

[Metastasis of germ cell tumors of the testis].

Machover D, Goldschmidt E.

Ann Urol (Paris). 1991;25(6-7):304-12. Review. French.

PMID:
1665326
34.

Monitoring and treatment of minimal residual cancer of the prostate.

Mathé G, Schally AV, Comaru-Schally AM, Mauvernay RY, Vovan ML, Machover D, Misset JL, Court B, Bouchard P, Duchier J, et al.

Bull Soc Sci Med Grand Duche Luxemb. 1989 Mar-Apr;126(1):65-74.

PMID:
2525968
35.
36.

Membranous nephropathy in a bone marrow transplant recipient.

Hiesse C, Goldschmidt E, Santelli G, Charpentier B, Machover D, Fries D.

Am J Kidney Dis. 1988 Feb;11(2):188-91.

PMID:
3277409
37.

Monitoring and treatment of minimal residual cancer of the prostate.

Mathé G, Schally AV, Comaru-Schally AM, Mauvernay RY, Vovan ML, Machover D, Misset JL, Court B, Bouchard P, Duchier J, et al.

Suppl J Med Oncol Tumor Pharmacother. 1988;1:65-74. Review. No abstract available.

PMID:
3074228
38.

[Therapeutic trials of aclarubicin in previously treated acute leukemias and hematosarcomas].

Machover D, Goldschmidt E, Benavides M, Gastiaburu J, Vandenbulcke JM, Delgado M, Misset JL, Mathe G.

Pathol Biol (Paris). 1987 Jan;35(1):79-86. French.

PMID:
3550616
39.

Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.

Machover D, Goldschmidt E, Chollet P, Metzger G, Zittoun J, Benavides M, Marquet J, Vandenbulcke JM, Misset JL, Schwarzenberg L, et al.

NCI Monogr. 1987;(5):193-8.

PMID:
3501542
40.

Phase I-II study of aclarubicin for treatment of acute myeloid leukaemia.

Machover D, Gastiaburu J, Delgado M, Goldschmidt E, Hulhoven R, Benavides M, Lotz JP, Misset JL, de Vassal F, Tapiero H, et al.

Eur J Haematol Suppl. 1987;47:33-42. No abstract available.

PMID:
3471523
41.

Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.

Machover D, Goldschmidt E, Chollet P, Metzger G, Zittoun J, Marquet J, Vandenbulcke JM, Misset JL, Schwarzenberg L, Fourtillan JB, et al.

J Clin Oncol. 1986 May;4(5):685-96.

PMID:
3517242
42.

Excess of lympho-reticular cell complexes in the bone marrow linked to T cell mediated dysmyelopoiesis.

Blazsek I, Goldschmidt E, Machover D, Misset JL, Benavides M, Comisso M, Ceresi E, Canon C, Labat ML, Mathé G.

Biomed Pharmacother. 1986;40(1):28-32.

PMID:
3486680
43.

Phase II trial with D-Trp-6-LH-RH in prostatic carcinoma: comparison with other hormonal agents.

Mathé G, Schally AV, Comaru-Schally AM, Mauvernay RY, Vovan ML, Machover D, Misset JL, Court B, Bouchard P, Duchier J, et al.

Prostate. 1986;9(4):327-42.

PMID:
2947053
44.

[Advanced cancer of the prostate. Treatment with an LH-RH agonist, D-Trp-6-LH-RH].

Mathé G, Misset JL, Vovan ML, Machover D.

Bull Cancer. 1986;73(1):31-5. French.

PMID:
2430652
45.

Establishment and characterization of a new human eosinophilic leukemia cell line.

Saito H, Bourinbaiar A, Ginsburg M, Minato K, Ceresi E, Yamada K, Machover D, Bréard J, Mathé G.

Blood. 1985 Dec;66(6):1233-40.

PMID:
2415185
46.

Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil combined with high-dose folinic acid. An update.

Machover D, Goldschmidt E, Schwarzenberg L, Vanden-Bulcke JM, Misset JL, Chollet P, Mathé G.

Chemioterapia. 1985 Oct;4(5):369-76.

PMID:
3878231
47.

[A case of septicemia by a Corynebacterium of the J. K. group].

Mathieu D, Misset JL, Chardans B, Machover D, Goldschmidt E, Jacques L.

Biomed Pharmacother. 1985;39(4):173-6. French.

PMID:
4063466
48.

Phase I-II study of aclarubicin for treatment of acute myeloid leukemia.

Machover D, Gastiaburu J, Delgado M, Goldschmidt E, Hulhoven R, Misset JL, de Vassal F, Tapiero H, Ribaud P, Schwarzenberg L, et al.

Cancer Treat Rep. 1984 Jun;68(6):881-6.

PMID:
6587933
49.

Treatment of acute myeloid leukemia with a combination of intensive induction chemotherapy, early consolidation, splenectomy and long-term maintenance chemotherapy.

Machover D, Rappaport H, Schwarzenberg L, Misset JL, Goldschmidt E, Lemaigre G, Dorval T, De Vassal F, Ribaud P, Gaget H, et al.

Cancer. 1984 Apr 15;53(8):1644-50.

PMID:
6582996
50.

Phase I-II study of aclacinomycin for a treatment of acute myeloid leukemia.

Machover D, Gastiaburu J, Delgado M, Goldschmidt E, Hulhoven R, Misset JL, de Vassal F, Tapiero H, Dorval T, Ribaud P, et al.

Biomed Pharmacother. 1984;38(7):328-31.

PMID:
6596962

Supplemental Content

Loading ...
Support Center